Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inspire Medical Systems (INSP) Gross Profit (2017 - 2025)

Inspire Medical Systems' Gross Profit history spans 9 years, with the latest figure at $233.0 million for Q4 2025.

  • For Q4 2025, Gross Profit rose 14.37% year-over-year to $233.0 million; the TTM value through Dec 2025 reached $778.8 million, up 14.55%, while the annual FY2025 figure was $778.8 million, 14.55% up from the prior year.
  • Gross Profit for Q4 2025 was $233.0 million at Inspire Medical Systems, up from $192.7 million in the prior quarter.
  • Across five years, Gross Profit topped out at $233.0 million in Q4 2025 and bottomed at $34.4 million in Q1 2021.
  • The 5-year median for Gross Profit is $127.9 million (2023), against an average of $126.4 million.
  • The largest annual shift saw Gross Profit skyrocketed 344.24% in 2021 before it grew 9.86% in 2025.
  • A 5-year view of Gross Profit shows it stood at $67.2 million in 2021, then surged by 72.14% to $115.7 million in 2022, then surged by 42.08% to $164.5 million in 2023, then rose by 23.88% to $203.7 million in 2024, then increased by 14.37% to $233.0 million in 2025.
  • Per Business Quant, the three most recent readings for INSP's Gross Profit are $233.0 million (Q4 2025), $192.7 million (Q3 2025), and $182.4 million (Q2 2025).